|
Volumn 16, Issue SUPPL. 1, 2002, Pages
|
Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry
|
Author keywords
International regulatory guidelines; Maximum tolerated dose; Positron emission tomography; Sequential cohort design
|
Indexed keywords
ALZHEIMER DISEASE;
DRUG APPROVAL;
DRUG DEVELOPMENT;
DRUG INDUSTRY;
DRUG RESEARCH;
INTERNATIONAL COOPERATION;
POSITRON EMISSION TOMOGRAPHY;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
REVIEW;
|
EID: 0036279781
PISSN: 08930341
EISSN: None
Source Type: Journal
DOI: 10.1097/00002093-200200001-00006 Document Type: Review |
Times cited : (6)
|
References (22)
|